Toggle navigation
Home
Search
Services
Blog
Contact
About
CD45 Isoform Regulation of T Cell Activation
Leitenberg, David
Yale University, New Haven, CT, United States
Search 8 grants from David Leitenberg
Search grants from Yale University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Integrated Technologies for Weight and Blood Pressure Control in Urban Clinics
Neuronal Acetylcholine Receptor Mechanisms
Laser Device for IN Situ Monitoring of Crystallization
Neurohormones in the Pathophysiology and Pathogenesis of Depression
Cytolytic Mechanism of T Lymphocytes
Recently added grants:
Targeting Metabolic Liabilities in Cancer
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Cancer genes: translating basics to applications
Resistance and Sensitivity to MET Inhibitors in Lung Cancer
Obesity, Metabolism and Breast Cancer Metastasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AI001314-02
Application #
2057599
Study Section
Allergy & Clinical Immunology-1 (AITC)
Project Start
1995-08-01
Project End
1998-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Yale University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Related projects
NIH 1997
K08 AI
CD45 Isoform Regulation of T Cell Activation
Leitenberg, David / Yale University
NIH 1996
K08 AI
CD45 Isoform Regulation of T Cell Activation
Leitenberg, David / Yale University
NIH 1995
K08 AI
CD45 Isoform Regulation of T Cell Activation
Leitenberg, David / Yale University
Publications
Boutin, Y; Leitenberg, D; Tao, X et al.
(1997)
Distinct biochemical signals characterize agonist- and altered peptide ligand-induced differentiation of naive CD4+ T cells into Th1 and Th2 subsets.
J Immunol 159:5802-9
Comments
Be the first to comment on David Leitenberg's grant